HAYWARD, Calif., January 08, 2026--(BUSINESS WIRE)--RefleXion Medical, an external-beam theranostic oncology company, today announced the U.S. Food and Drug Administration has cleared its next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results